Immune checkpoints like programmed cell death protein 1 (PD-1) and programmed cell death protein ligand 1 (PD-L1) promote immune tolerance and, when activated, can facilitate tumour progression [29,30]. This evidence concerns the gene CD274 and neoplasm.